Jirong Long
Last active: 2/15/2016

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Whole-Exome Sequencing Identifies Novel Somatic Mutations in Chinese Breast Cancer Patients. Zhang Y, Cai Q, Shu XO, Gao YT, Li C, Zheng W, Long J (2015) J Mol Genet Med 9(4)
    › Primary publication · 26870154 (PubMed) · PMC4747093 (PubMed Central)
  2. Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. Han MR, Deming-Halverson S, Cai Q, Wen W, Shrubsole MJ, Shu XO, Zheng W, Long J (2015) Breast Cancer 22(5): 544-51
    › Primary publication · 24510657 (PubMed) · PMC4127164 (PubMed Central)
  3. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies. Zhang Y, Long J, Lu W, Shu XO, Cai Q, Zheng Y, Li C, Li B, Gao YT, Zheng W (2014) Cancer Epidemiol Biomarkers Prev 23(4): 622-8
    › Primary publication · 24470074 (PubMed) · PMC3976694 (PubMed Central)
  4. Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians. Zhang B, Jia WH, Matsuo K, Shin A, Xiang YB, Matsuda K, Jee SH, Kim DH, Cheah PY, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Ji BT, Pan ZZ, Matsuda F, Gao YT, Oh JH, Ahn YO, Kubo M, Thean LF, Park EJ, Li HL, Park JW, Jo J, Jeong JY, Hosono S, Nakamura Y, Shu XO, Zeng YX, Zheng W (2014) Int J Cancer 135(4): 948-55
    › Primary publication · 24448986 (PubMed) · PMC4051826 (PubMed Central)
  5. No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women. Dorjgochoo T, Zheng Y, Gao YT, Ma X, Long J, Bao P, Zhang B, Wen W, Lu W, Zheng W, Shu XO, Beeghly-Fadiel A (2013) Cancer Epidemiol 37(5): 619-24
    › Primary publication · 23850146 (PubMed) · PMC4064366 (PubMed Central)
  6. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, Choi JY, Long J, Dennis J, Humphreys MK, Wang Q, Lu W, Gao YT, Li C, Cai H, Park SK, Yoo KY, Noh DY, Han W, Dunning AM, Benitez J, Vincent D, Bacot F, Tessier D, Kim SW, Lee MH, Lee JW, Lee JY, Xiang YB, Zheng Y, Wang W, Ji BT, Matsuo K, Ito H, Iwata H, Tanaka H, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Teo SH, Yip CH, Kang IN, Wong TY, Shen CY, Yu JC, Huang CS, Hou MF, Hartman M, Miao H, Lee SC, Putti TC, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Sangrajrang S, Shen H, Chen K, Wu PE, Ren Z, Haiman CA, Sueta A, Kim MK, Khoo US, Iwasaki M, Pharoah PD, Wen W, Hall P, Shu XO, Easton DF, Kang D (2013) Hum Mol Genet 22(12): 2539-50
    › Primary publication · 23535825 (PubMed) · PMC3658167 (PubMed Central)
  7. A common deletion in the APOBEC3 genes and breast cancer risk. Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q, Xiang YB, Li C, Ji BT, Zheng Y, Ali S, Shu XO, Zheng W (2013) J Natl Cancer Inst 105(8): 573-9
    › Primary publication · 23411593 (PubMed) · PMC3627644 (PubMed Central)
  8. No association between ovarian cancer susceptibility variants and breast cancer risk among Chinese women. Ma X, Cai Q, Delahanty RJ, Shu XO, Zhang B, Lu W, Gao YT, Zheng W, Long J, Beeghly-Fadiel A (2013) Cancer Epidemiol Biomarkers Prev 22(3): 467-9
    › Primary publication · 23292081 (PubMed) · PMC3596432 (PubMed Central)
  9. Polymorphisms in inflammation pathway genes and endometrial cancer risk. Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, Beckmann MW, Coenegrachts L, Coosemans A, Dubrowinskaja N, Dunning A, Runnebaum IB, Easton D, Ekici AB, Fasching PA, Halle MK, Hein A, Howarth K, Gorman M, Kaydarova D, Krakstad C, Lose F, Lu L, Lurie G, O'Mara T, Matsuno RK, Pharoah P, Risch H, Corssen M, Trovik J, Turmanov N, Wen W, Lu W, Cai Q, Zheng W, Shu XO (2013) Cancer Epidemiol Biomarkers Prev 22(2): 216-23
    › Primary publication · 23221126 (PubMed) · PMC3677562 (PubMed Central)
  10. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians. Ma X, Beeghly-Fadiel A, Lu W, Shi J, Xiang YB, Cai Q, Shen H, Shen CY, Ren Z, Matsuo K, Khoo US, Iwasaki M, Long J, Zhang B, Ji BT, Zheng Y, Wang W, Hu Z, Liu Y, Wu PE, Shieh YL, Wang S, Xie X, Ito H, Kasuga Y, Chan KY, Iwata H, Tsugane S, Gao YT, Shu XO, Moses HL, Zheng W (2012) Cancer Epidemiol Biomarkers Prev 21(7): 1176-84
    › Primary publication · 22539603 (PubMed) · PMC3810157 (PubMed Central)
  11. Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Long J, Zheng W, Xiang YB, Lose F, Thompson D, Tomlinson I, Yu H, Wentzensen N, Lambrechts D, Dörk T, Dubrowinskaja N, Goodman MT, Salvesen HB, Fasching PA, Scott RJ, Delahanty R, Zheng Y, O'Mara T, Healey CS, Hodgson S, Risch H, Yang HP, Amant F, Turmanov N, Schwake A, Lurie G, Trovik J, Beckmann MW, Ashton K, Ji BT, Bao PP, Howarth K, Lu L, Lissowska J, Coenegrachts L, Kaidarova D, Dürst M, Thompson PJ, Krakstad C, Ekici AB, Otton G, Shi J, Zhang B, Gorman M, Brinton L, Coosemans A, Matsuno RK, Halle MK, Hein A, Proietto A, Cai H, Lu W, Dunning A, Easton D, Gao YT, Cai Q, Spurdle AB, Shu XO (2012) Cancer Epidemiol Biomarkers Prev 21(6): 980-7
    › Primary publication · 22426144 (PubMed) · PMC3372671 (PubMed Central)
  12. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, Wen W, Delahanty RJ, Lu W, Gao YT, Shen H, Park SK, Chen K, Shen CY, Ren Z, Haiman CA, Matsuo K, Kim MK, Khoo US, Iwasaki M, Zheng Y, Xiang YB, Gu K, Rothman N, Wang W, Hu Z, Liu Y, Yoo KY, Noh DY, Han BG, Lee MH, Zheng H, Zhang L, Wu PE, Shieh YL, Chan SY, Wang S, Xie X, Kim SW, Henderson BE, Le Marchand L, Ito H, Kasuga Y, Ahn SH, Kang HS, Chan KY, Iwata H, Tsugane S, Li C, Shu XO, Kang DH, Zheng W (2012) PLoS Genet 8(2): e1002532
    › Primary publication · 22383897 (PubMed) · PMC3285588 (PubMed Central)
  13. Replication study for reported SNP associations with breast cancer survival. Beeghly-Fadiel A, Zheng W, Lu W, Long J, Zheng Y, Cai H, Gu K, Chen Z, Cai Q, Gao YT, Shu XO (2012) J Cancer Res Clin Oncol 138(6): 1019-26
    › Primary publication · 22367361 (PubMed) · PMC3810152 (PubMed Central)
  14. Novel genetic markers of breast cancer survival identified by a genome-wide association study. Shu XO, Long J, Lu W, Li C, Chen WY, Delahanty R, Cheng J, Cai H, Zheng Y, Shi J, Gu K, Wang WJ, Kraft P, Gao YT, Cai Q, Zheng W (2012) Cancer Res 72(5): 1182-9
    › Primary publication · 22232737 (PubMed) · PMC3294129 (PubMed Central)
  15. Genetic polymorphisms in obesity-related genes and endometrial cancer risk. Chen X, Xiang YB, Long JR, Cai H, Cai Q, Cheng J, Wen W, Gao YT, Zheng W, Shu XO (2012) Cancer 118(13): 3356-64
    › Primary publication · 22038736 (PubMed) · PMC3270123 (PubMed Central)
  16. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, Lee JY, Chen K, Shen H, Shen CY, Sung H, Matsuo K, Haiman CA, Khoo US, Ren Z, Iwasaki M, Gu K, Xiang YB, Choi JY, Park SK, Zhang L, Hu Z, Wu PE, Noh DY, Tajima K, Henderson BE, Chan KY, Su F, Kasuga Y, Wang W, Cheng JR, Yoo KY, Lee JY, Zheng H, Liu Y, Shieh YL, Kim SW, Lee JW, Iwata H, Le Marchand L, Chan SY, Xie X, Tsugane S, Lee MH, Wang S, Li G, Levy S, Huang B, Shi J, Delahanty R, Zheng Y, Li C, Gao YT, Shu XO, Zheng W (2011) Hum Mol Genet 20(24): 4991-9
    › Primary publication · 21908515 (PubMed) · PMC3221542 (PubMed Central)
  17. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, Gu K, Gao YT, Zheng W, Shu XO (2011) Cancer Epidemiol Biomarkers Prev 20(10): 2313-6
    › Primary publication · 21828234 (PubMed) · PMC3189282 (PubMed Central)
  18. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Lancet Oncol 12(5): 477-88
    › Primary publication · 21514219 (PubMed) · PMC3114278 (PubMed Central)
  19. Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. Zhang B, Beeghly-Fadiel A, Lu W, Cai Q, Xiang YB, Zheng Y, Long J, Ye C, Gu K, Shu XO, Gao Y, Zheng W (2011) Am J Epidemiol 173(10): 1159-70
    › Primary publication · 21454829 (PubMed) · PMC3121323 (PubMed Central)
  20. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. Cai H, Xiang YB, Qu S, Long J, Cai Q, Gao J, Zheng W, Shu XO (2011) Am J Epidemiol 173(11): 1263-71
    › Primary publication · 21454826 (PubMed) · PMC3101066 (PubMed Central)
  21. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, Deming SL, Shen H, Shen CY, Gammon MD, Blot WJ, Matsuo K, Haiman CA, Khoo US, Iwasaki M, Santella RM, Zhang L, Fair AM, Hu Z, Wu PE, Signorello LB, Titus-Ernstoff L, Tajima K, Henderson BE, Chan KY, Kasuga Y, Newcomb PA, Zheng H, Cui Y, Wang F, Shieh YL, Iwata H, Le Marchand L, Chan SY, Shrubsole MJ, Trentham-Dietz A, Tsugane S, Garcia-Closas M, Long J, Li C, Shi J, Huang B, Xiang YB, Gao YT, Lu W, Shu XO, Zheng W (2011) Cancer Res 71(4): 1344-55
    › Primary publication · 21303983 (PubMed) · PMC3083305 (PubMed Central)
  22. Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women. Li G, Xiang YB, Courtney R, Cheng JR, Huang B, Long JR, Cai H, Zheng W, Shu XO, Cai Q (2011) Chin J Cancer 30(2): 138-43
    › Primary publication · 21272446 (PubMed) · PMC3842219 (PubMed Central)
  23. Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Beeghly-Fadiel A, Shu XO, Lu W, Long J, Cai Q, Xiang YB, Zheng Y, Zhao Z, Gu K, Gao YT, Zheng W (2011) Cancer Epidemiol Biomarkers Prev 20(1): 33-41
    › Primary publication · 21119072 (PubMed) · PMC3336364 (PubMed Central)
  24. MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study. Beeghly-Fadiel A, Lu W, Shu XO, Long J, Cai Q, Xiang Y, Gao YT, Zheng W (2011) Breast Cancer Res Treat 126(2): 507-13
    › Primary publication · 20725776 (PubMed) · PMC3345163 (PubMed Central)
  25. Evaluation of genetic susceptibility loci for obesity in Chinese women. Shi J, Long J, Gao YT, Lu W, Cai Q, Wen W, Zheng Y, Yu K, Xiang YB, Hu FB, Zheng W, Shu XO (2010) Am J Epidemiol 172(3): 244-54
    › Primary publication · 20616199 (PubMed) · PMC2917056 (PubMed Central)
  26. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, Gu K, Wang W, Xiang YB, Cheng J, Chen K, Zhang L, Zheng H, Shen CY, Huang CS, Hou MF, Shen H, Hu Z, Wang F, Deming SL, Kelley MC, Shrubsole MJ, Khoo US, Chan KY, Chan SY, Haiman CA, Henderson BE, Le Marchand L, Iwasaki M, Kasuga Y, Tsugane S, Matsuo K, Tajima K, Iwata H, Huang B, Shi J, Li G, Wen W, Gao YT, Lu W, Zheng W (2010) PLoS Genet 6(6): e1001002
    › Primary publication · 20585626 (PubMed) · PMC2891809 (PubMed Central)
  27. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, Li G, Li C, Gu K, Cai Q, Shu XO, Lu W (2010) J Natl Cancer Inst 102(13): 972-81
    › Primary publication · 20484103 (PubMed) · PMC2897876 (PubMed Central)
  28. E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Beeghly-Fadiel A, Lu W, Gao YT, Long J, Deming SL, Cai Q, Zheng Y, Shu XO, Zheng W (2010) Breast Cancer Res Treat 121(2): 445-52
    › Primary publication · 19834798 (PubMed) · PMC2874636 (PubMed Central)
  29. Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk. Ye C, Beeghly-Fadiel A, Lu W, Long J, Shu XO, Gao YT, Zheng W, Cai Q (2010) Breast Cancer Res Treat 121(3): 765-9
    › Primary publication · 19798569 (PubMed) · PMC3493111 (PubMed Central)
  30. Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility. Beeghly-Fadiel A, Lu W, Long JR, Shu XO, Zheng Y, Cai Q, Gao YT, Zheng W (2009) Cancer Epidemiol Biomarkers Prev 18(6): 1770-6
    › Primary publication · 19454611 (PubMed) · PMC2747044 (PubMed Central)
  31. No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk. Beeghly-Fadiel A, Xiang YB, Deming SL, Long JR, Xu WH, Cai Q, Zheng W, Shu XO (2009) Cancer Epidemiol Biomarkers Prev 18(6): 1925-8
    › Primary publication · 19435861 (PubMed) · PMC2770800 (PubMed Central)
  32. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival. Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, Zheng W (2009) Int J Cancer 125(4): 844-50
    › Primary publication · 19431211 (PubMed) · PMC2745995 (PubMed Central)
  33. No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study. Beeghly-Fadiel A, Cai Q, Lu W, Long J, Gao YT, Shu XO, Zheng W (2009) Cancer Epidemiol Biomarkers Prev 18(4): 1324-7
    › Primary publication · 19318431 (PubMed) · PMC2701308 (PubMed Central)
  34. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, Wen W, Levy S, Deming SL, Haines JL, Gu K, Fair AM, Cai Q, Lu W, Shu XO (2009) Nat Genet 41(3): 324-8
    › Primary publication · 19219042 (PubMed) · PMC2754845 (PubMed Central)
  35. A two-stage case-control study of EGFR polymorphisms and breast cancer risk. Hong YS, Deming SL, Gao YT, Long JR, Shu XO, Cai Q, Lu W, Zheng W (2009) Cancer Epidemiol Biomarkers Prev 18(2): 680-3
    › Primary publication · 19190167 (PubMed) · PMC2702716 (PubMed Central)
  36. Genetic polymorphisms in the MMP-7 gene and breast cancer survival. Beeghly-Fadiel A, Shu XO, Long J, Li C, Cai Q, Cai H, Gao YT, Zheng W (2009) Int J Cancer 124(1): 208-14
    › Primary publication · 18798254 (PubMed) · PMC2597698 (PubMed Central)
  37. Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Qu S, Long J, Cai Q, Shu XO, Cai H, Gao YT, Zheng W (2008) Clin Cancer Res 14(15): 4787-93
    › Primary publication · 18676749 (PubMed) · PMC2713865 (PubMed Central)
  38. Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Beeghly-Fadiel A, Long JR, Gao YT, Li C, Qu S, Cai Q, Zheng Y, Ruan ZX, Levy SE, Deming SL, Snoddy JR, Shu XO, Lu W, Zheng W (2008) Cancer Res 68(15): 6453-9
    › Primary publication · 18648013 (PubMed) · PMC2718434 (PubMed Central)
  39. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Cai H, Shu XO, Egan KM, Cai Q, Long JR, Gao YT, Zheng W (2008) Pharmacogenet Genomics 18(8): 657-64
    › Primary publication · 18622258 (PubMed) · PMC2613759 (PubMed Central)
  40. Evaluating cost efficiency of SNP chips in genome-wide association studies. Li C, Li M, Long JR, Cai Q, Zheng W (2008) Genet Epidemiol 32(5): 387-95
    › Primary publication · 18271056 (PubMed) · PMC2650398 (PubMed Central)
  41. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Shin A, Shrubsole MJ, Rice JM, Cai Q, Doll MA, Long J, Smalley WE, Shyr Y, Sinha R, Ness RM, Hein DW, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17(2): 320-9
    › Primary publication · 18268115 (PubMed) · PMC2572782 (PubMed Central)
  42. IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study. Deming SL, Ren Z, Cai Q, Shu XO, Wen W, Long JR, Gao YT, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17(1): 255-7
    › Primary publication · 18199734 (PubMed) · PMC2646902 (PubMed Central)
  43. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Long JR, Cai Q, Shu XO, Cai H, Gao YT, Zheng W (2007) Pharmacogenet Genomics 17(5): 331-8
    › Primary publication · 17429315 (PubMed)
  44. Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer. Dai Q, Xu WH, Long JR, Courtney R, Xiang YB, Cai Q, Cheng J, Zheng W, Shu XO (2007) Pharmacogenet Genomics 17(2): 161-7
    › Primary publication · 17301695 (PubMed) · PMC2238679 (PubMed Central)
  45. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. Long JR, Kataoka N, Shu XO, Wen W, Gao YT, Cai Q, Zheng W (2006) Cancer Epidemiol Biomarkers Prev 15(11): 2115-22
    › Primary publication · 17119036 (PubMed)
  46. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W (2006) Pharmacogenet Genomics 16(4): 237-43
    › Primary publication · 16538170 (PubMed)